Chemoinformaics analysis of 13-Trans-cinnamoyloxylupanine
| Molecular Weight | 394.515 | nRot | 3 |
| Heavy Atom Molecular Weight | 364.275 | nRig | 29 |
| Exact Molecular Weight | 394.226 | nRing | 5 |
| Solubility: LogS | -3.64 | nHRing | 4 |
| Solubility: LogP | 3.007 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 59 | No. of Aliphatic Hetero Cycles | 4 |
| No. of Heavy Atom | 29 | No. of Aromatic Carbocycles | 1 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 4 |
| No. of Carbon atom | 24 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 6 |
| nHA | 4 | APOL | 64.6898 |
| nHD | 0 | BPOL | 36.9882 |
| QED | 0.584 |
| Synth | 4.583 |
| Natural Product Likeliness | 0.969 |
| NR-PPAR-gamma | 0.122 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.222 |
| Pgp-sub | 0.088 |
| HIA | 0.072 |
| CACO-2 | -4.826 |
| MDCK | 0.0000639 |
| BBB | 0.835 |
| PPB | 0.684292 |
| VDSS | 1.643 |
| FU | 0.344205 |
| CYP1A2-inh | 0.034 |
| CYP1A2-sub | 0.085 |
| CYP2c19-inh | 0.068 |
| CYP2c19-sub | 0.407 |
| CYP2c9-inh | 0.032 |
| CYP2c9-sub | 0.919 |
| CYP2d6-inh | 0.893 |
| CYP2d6-sub | 0.825 |
| CYP3a4-inh | 0.745 |
| CYP3a4-sub | 0.635 |
| CL | 9.254 |
| T12 | 0.328 |
| hERG | 0.323 |
| Ames | 0.012 |
| ROA | 0.011 |
| SkinSen | 0.961 |
| Carcinogencity | 0.415 |
| EI | 0.055 |
| Respiratory | 0.639 |
| NR-Aromatase | 0.023 |
| Antiviral | Yes |
| Prediction | 0.723198 |